Geoffrey Lindeman

34PUBLICATIONS
167CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|May 28, 2025
Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer.

Ing S Tiong, Tamia Nguyen, Chong C Chua

|Apr 11, 2025
Fibroblast hierarchy dynamics during mammary gland morphogenesis and tumorigenesis.

Rosa Pascual, Jinming Cheng, Amelia H De Smet

|Mar 23, 2025
MCL‑1 safeguards activated hair follicle stem cells to enable adult hair regeneration.

Hui San Chin, Jinming Cheng, Shih Han Hsu

|Oct 29, 2024
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia.

Meng-Xiao Luo, Tania Tan, Marie Trussart

|Jun 24, 2024
Author Correction: Inhibition of lysine acetyltransferase KAT6 in ER<sup>+</sup>HER2<sup>-</sup> metastatic breast cancer: a phase 1 trial.

Toru Mukohara, Yeon Hee Park, David Sommerhalder

|Jun 01, 2024
Inhibition of lysine acetyltransferase KAT6 in ER<sup>+</sup>HER2<sup>-</sup> metastatic breast cancer: a phase 1 trial.

Toru Mukohara, Yeon Hee Park, David Sommerhalder

Pageof 6

Frequent Collaborators

16 joint publications

Gordon K Smyth

15 joint publications

François Vaillant

13 joint publications

Jane E Visvader

7 joint publications

Bhupinder Pal